Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. - Wikidata - awgldk - TriplyDB

Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.

Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q37328297

about

Th17 cells in autoimmune and infectious diseases Risk of non-Hodgkin lymphoma in association with germline variation in complement genes Identification of predictive pathways for non-hodgkin lymphoma prognosis Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.Cancer incidence among paraquat exposed applicators in the agricultural health study: prospective cohort study.Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma Host genetics in follicular lymphoma Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis.Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk.Association between tumor necrosis factor-α gene polymorphisms and diffuse large B-cell lymphoma in Chinese Han population: evidence from two center case-control study and a meta-analysis.Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study Association between genetic variations in tumor necrosis factor receptor genes and survival of patients with T-cell lymphoma.Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.Candidate gene association studies and risk of chronic lymphocytic leukemia: a systematic review and meta-analysis.Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies.Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma.Possible Role of Polymorphisms in TNFA, NFKB1, and CASP8 Gene Promoter Areas in the Development of Chronic Lymphocytic Leukemia.CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL).Genetic Variations of Tumor Necrosis Factor -α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients.TRAF5 and TRAF3IP2 gene polymorphisms are associated with Behçet's disease and Vogt-Koyanagi-Harada syndrome: a case-control study.Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis.TNF-β +252 A>G polymorphism and susceptibility to cancer.Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features.Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.

P2860

Q21284677-6C8C88DA-DC83-401E-94E4-841B13142951 Q24648778-50E80354-EC78-48A0-AD28-DA4969AF5A62 Q30497902-685B72DA-36B9-4D7A-899F-0A3A91ACDA45 Q33434511-267BB21C-F55A-4D00-9CFC-652D8F723F92 Q33741481-D74C6B43-8A03-4D0F-9DBC-2B76DE87DB4B Q33930843-5426E98C-A889-4251-872D-6A41A8F0868B Q34292891-BA8137A2-7CD3-441B-B2F7-00F7E8B1950E Q34683721-83A6D8CB-84A8-4F6C-AF0F-AE67EEE9F70F Q35009957-85E71159-C3EA-406B-A1A6-4379BF449B1E Q35031964-5D2D6FF3-F2AD-4A13-A05E-03F220A56B3D Q35038312-04FB06A6-73A8-4701-BCFE-27339EEDF698 Q35070335-759425E7-B5BC-4CB8-A161-7AE744ECEEA2 Q35210306-B9489016-00AC-4A67-911F-159CB2AAB663 Q36306403-C11B4C87-DA87-489D-8579-7FBD54E1611C Q36360694-16915DA3-F872-4773-99E3-37BB0DBB32C9 Q36375294-DF18E7B7-D1D9-4A54-AA0A-0CCBD62ED142 Q36622888-9CF0D2C3-2B6D-4A3B-ADCF-F98126CB9D27 Q36729256-8CFAE8DA-E18E-4625-9C08-451E966B6F17 Q37183715-96457D21-FFFD-4DA1-AB9D-C6BDB37D7607 Q37345560-BF59EEC7-2749-47B5-AD06-8B4FB21DD3FA Q38104390-5E0619D3-C145-421E-92D0-3B60106BDE71 Q38403881-E15467F7-72B2-4279-B015-D69F8201EA09 Q38516259-E6697431-441E-420D-A03E-4D4E93E4A63A Q38865465-A5B3E544-3557-43BA-BE45-08B748418C2E Q39506851-22D1ACD8-7EF1-464A-A9F2-C221C3D8EC22 Q41854152-F33BD7BE-0E4F-4116-AB82-E5871A97A085 Q41860239-51474B3A-4E03-43F0-96B4-DAA69726F1EE Q42591459-DD3A8219-9E88-47D3-96A2-F1C486506C8C Q43535631-E8119FB1-B57A-47EB-8628-3483DF7597F6 Q43759426-552D3A2C-904F-4C89-8F7D-23FE146F4A89 Q45590471-BAD3EB61-91BD-493F-8511-661591CA4169 Q45913850-1B1B401B-A94D-408F-880F-15A2D0879719 Q47780867-61EFCD28-4D8F-4C6C-A65F-0F4A730022F9

P2860

Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q37328297

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Genetic variation in tumor nec ...... isk of non-Hodgkin's lymphoma.

@en

Genetic variation in tumor nec ...... isk of non-Hodgkin's lymphoma.

@nl

type

label

Genetic variation in tumor nec ...... isk of non-Hodgkin's lymphoma.

@en

Genetic variation in tumor nec ...... isk of non-Hodgkin's lymphoma.

@nl

prefLabel

Genetic variation in tumor nec ...... isk of non-Hodgkin's lymphoma.

@en

Genetic variation in tumor nec ...... isk of non-Hodgkin's lymphoma.

@nl

P1433

Q37328297-31B259A2-4EB7-4040-A0C7-2C362A2A9FA3

P1476

Q37328297-410BA171-BE55-4807-98AD-4E2C241C3962

P2093

Q37328297-15C8A1BA-93BC-4B90-8216-8EF430323BD2

Q37328297-209C61CD-17BD-4143-A230-19E2BC8C4167

Q37328297-2B11A66F-2D3E-4AC1-9031-376AE9AA7636

Q37328297-3C62ED67-A0B2-496F-98D7-BEE15C237E28

Q37328297-7E542C61-AC5B-4CC4-9CDD-F3A6E0683374

Q37328297-97B4F254-55E2-461F-A0B5-E061FD1EA52F

Q37328297-9DE82A3B-19B4-436A-9294-0CA2D907CD81

Q37328297-D2AAD316-FBE2-437E-95D2-E615F684A0E0

Q37328297-D9866D11-10D9-44E1-ADBE-99F2EABAE372

Q37328297-FF8E3F16-5EE4-4C79-ADEC-14DF4B28923E

P2860

Q37328297-112FB1CD-76E2-4E51-8F9E-5C62A742BE2E

Q37328297-184BE669-EF7D-41A1-80C1-285E856838F9

Q37328297-1A1E8274-DC30-417F-B466-1A3102B39C16

Q37328297-3580D655-20BE-44BE-A7E9-E61A855289C1

Q37328297-3AFA57E6-CEB1-4799-B388-53ACD81BD82A

Q37328297-533C7C65-D096-4A90-8D84-5E9D25D250C7

Q37328297-62CA3576-078F-414E-8609-3C70188DE612

Q37328297-663FB7E4-468A-420B-9F56-DC2C3A0C77A8

Q37328297-6EBB1125-3DF3-4B83-8FEF-8345C1F1491C

Q37328297-74A21BA4-E05C-4F7E-917B-683C6116E34F

P304

Q37328297-1B0F8571-4772-4697-8B19-5B6664ABBFCA

P31

Q37328297-7475F0D5-E8C8-4DEE-AE07-5043C8484CA0

P356

Q37328297-8084E1F6-80CE-41AF-8A15-A718418C8986

P433

Q37328297-7E1BD917-F0AF-417E-92F8-D4EEB33740CB

P478

Q37328297-C8975A87-ACC2-41DD-82CE-804394470267

P50

Q37328297-422B4F99-B933-460F-8C68-78A3CD4BD4AD

Q37328297-CB2096C7-9A20-4F25-8418-C63224D61096

Q37328297-F9F2A318-4525-4270-BE9F-D767133BC250

P577

Q37328297-35FDAB84-67C4-4B2E-B538-46BB461148A9

P698

Q37328297-6C03F53B-A854-4EFA-9383-A520DADB4A1D

P932

Q37328297-D7544B11-F99B-4D1B-AE3F-1F17B6006224

P356

1055-9965.EPI-08-0536

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Genetic variation in tumor nec ...... isk of non-Hodgkin's lymphoma.

@en

P2093

Ahmet Dogan

http://www.w3.org/2001/XMLSchema#string

Alice H Wang

http://www.w3.org/2001/XMLSchema#string

Mark Liebow

http://www.w3.org/2001/XMLSchema#string

Neil E Kay

http://www.w3.org/2001/XMLSchema#string

Stephen M Ansell

http://www.w3.org/2001/XMLSchema#string

Susan L Slager

http://www.w3.org/2001/XMLSchema#string

Thomas M Habermann

http://www.w3.org/2001/XMLSchema#string

Timothy G Call

http://www.w3.org/2001/XMLSchema#string

Wen Liu-Mares

http://www.w3.org/2001/XMLSchema#string

Zachary S Fredericksen

http://www.w3.org/2001/XMLSchema#string

P2860

Inference of population structure using multilocus genotype data

Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay

From genotypes to genes: doubling the sample size

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

Score tests for association between traits and haplotypes when linkage phase is ambiguous

Genetic susceptibility to lymphoma

TNF-alpha gene polymorphism: clinical and biological implications.

Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications.

Is there a future for TNF promoter polymorphisms?

Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

P304

3161-3169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-08-0536

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Julie M. Cunningham

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18990758

http://www.w3.org/2001/XMLSchema#string

P932

2735864

http://www.w3.org/2001/XMLSchema#string